Abstracts tagged "[18F]FDG PET"

Abstract Number: 119 • 2019 ACR/ARP Annual Meeting
Mitochondrial Transplantation Suppressed Muscle Inflammation and Improved the Mitochondrial Dysfunction in C Protein-induced Myositis Model
Jeong Yeon Kim¹, Seon Uk Kim ², Ji soo Park ¹, Ji Hye Lee ³, Jae Hwan Shin ⁴, Do Wan Hwang ⁵, Yun Sang Lee ⁴, Jin Chul Paeng ⁴, Yong Soo Choi ⁶, Jung Wook hwang ⁷, Kyuboem Han ⁸, Chun Hyung Kim ⁸, Mi Jin Kim ⁸, Yeong-Wook Song ⁹ and Eun Young Lee ¹⁰, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Seoul, Republic of Korea, ²Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Republic of Korea, ³Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Seoul, Republic of Korea, ⁴Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea, ⁵Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea., Seoul, Republic of Korea, ⁶Department of Biotechnology, CHA University, Seongnam, Korea, Seongnam, Republic of Korea, ⁷Department of Biotechnology, CHA University, Seongnam, Korea., Seongnam, Republic of Korea, ⁸PAEAN Biotechnology Inc., Daejeon, Korea, Daejeon, Republic of Korea, ⁹Seoul National University Hospital, Seoul, Republic of Korea, ¹⁰Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea
Background/Purpose: Polymyositis is a chronic inflammatory myopathy associated with lymphocyte infiltration, especially CD8 + T cells to the muscle layer. C protein-induced myositis (CIM) is a murine…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.